{"entity":{"type":"insider","cik":"0001560959","url":"/insider/0001560959","json_url":"/insider/0001560959.json","name":"Horobin Joanna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2014-12-31","last":"2025-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Horobin Joanna","source":"filing","n_filings":4,"first_seen":"2014-12-31","last_seen":"2025-08-21"}],"transactions":[{"id":4141452,"accession":"0001104659-25-081441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-081441","line_url":"/filing/0001104659-25-081441#line-1","is_derivative":false,"issuer_cik":"0001560959","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001560959","owner_cik":"0001560959","owner_name":"Horobin Joanna","owner_display_name":"Horobin Joanna","owner_url":"/insider/0001560959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.17,"price_display":"27.17","price_state":"stated","total_value":135850.0,"total_display":"135,850.00","total_whole":"135,850","shares_owned_after":33755.0,"shares_owned_after_display":"33,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":2984763,"accession":"0000950170-24-070966","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-070966","line_url":"/filing/0000950170-24-070966","is_derivative":false,"issuer_cik":"0001560959","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001560959","owner_cik":"0001560959","owner_name":"Horobin Joanna","owner_display_name":"Horobin Joanna","owner_url":"/insider/0001560959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":32.988230117647056,"price_display":"32.99","price_state":"stated","total_value":280399.956,"total_display":"280,399.96","total_whole":"280,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-07","scope":"insider","n_lines":2},{"id":6253305,"accession":"0001179110-18-014194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-014194","line_url":"/filing/0001179110-18-014194#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001560959","owner_name":"Horobin Joanna","owner_display_name":"Horobin Joanna","owner_url":"/insider/0001560959","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":1035.0,"total_display":"1,035.00","total_whole":"1,035","shares_owned_after":2044.0,"shares_owned_after_display":"2,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-20","scope":"insider"},{"id":6483433,"accession":"0001104659-14-089661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-089661","line_url":"/filing/0001104659-14-089661#line-1","is_derivative":false,"issuer_cik":"0001526119","issuer_name":"Verastem, Inc.","issuer_ticker":"VSTM","issuer_name_source":null,"issuer_url":"/issuer/0001526119","owner_cik":"0001560959","owner_name":"Horobin Joanna","owner_display_name":"Horobin Joanna","owner_url":"/insider/0001560959","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":750.0,"shares_owned_after_display":"750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819576","name":"Liquidia Corp","url":"/issuer/0001819576","role":"Director","n_filings":1,"first_seen":"2025-08-21","last_seen":"2025-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Director","n_filings":1,"first_seen":"2024-06-07","last_seen":"2024-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2018-12-20","last_seen":"2018-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001526119","name":"Verastem, Inc.","url":"/issuer/0001526119","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2014-12-31","last_seen":"2014-12-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001560959","retrieved_at":"2026-08-26T23:32:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}